top of page
Updating the latest information on studies, developments,
and events related to Therabiopharma Inc.
A new research article on the high bioavailability of curcuRouge® has been published.
A systematic review* article, published in Functional Food Science journal, indicates that curcuRouge® has the highest relative bioavailability per mg curcumin among the commercially available absorption-enhanced curcumin formulations. * A systematic Review: An evaluation based on a systematic comparison of multiple relevant studies. [Summary of Results] A systematic review of bioavailability based on a per mg curcumin dose was performed from the published studies of commerci
Feb 9
Our project has been selected for the AMED's “Research Project for Practical Application of Innovative Cancer Therapy”.
Our research using TBP1901, a drug we have developed, has been selected for the “Research Project for Practical Application of Innovative...
Apr 2, 2025
The article on information of research publication on curcuRouge® has been renewed.
We have renewed video article on the clinical studies on (1) immune function and COVID-19 , (2) heart failure , and (3) knee...
Apr 2, 2025
Spring Health Support Campaign
Spring is a time of seasonal change, and the temperature difference is large, so it's easy to get sick. There are also many events and...
Mar 21, 2025
A new treatise on efficacy of curcuRouge® in COVID-19 patients has been published in the Journal of Health, Population and Nutrition.
On June 24, 2024, a paper on COVID-19 infection in curcuRouge® has been published in the Journal of Health, Population and Nutrition. A...
Jul 3, 2024
Seminar on curcuRouge was held at the 144th Annual Meeting of the Pharmaceutical Society of Japan.
On March 31, 2024, the 144th Annual Meeting of the Pharmaceutical Society of Japan/Sera Bio-Pharma Co. held a luncheon seminar (seminar...
Jun 4, 2024
bottom of page